Pregnancy Risk Among Oral Contraceptive Pill, Injectable Contraceptive, and Condom Users in Uganda, Zimbabwe, and Thailand
Authors:
- Markus J. SteinerMSMarkus J. Steiner
- Cynthia KwokCKCynthia Kwok
- Rosalie DominikRDRosalie Dominik
- Josaphat K. ByamugishaJBJosaphat K. Byamugisha
- Tsungai ChipatoTCTsungai Chipato
- Thulani MagwaliTMThulani Magwali
- Francis MmiroFMFrancis Mmiro
- Sungwal RugpaoSRSungwal Rugpao
- Somchai SriplienchanSSSomchai Sriplienchan
- Charles S. MorrisonCMCharles S. Morrison
- 1 November 2007
- journal article
- editorial
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 110 (5) , 1003-1009
Abstract
To estimate the probability of pregnancy for oral contraceptive pill (OCP), injectable contraceptive, and condom users in Uganda, Thailand, and Zimbabwe. This study is a secondary analysis of 5,224 women who participated in a prospective study evaluating the association between hormonal contraception and human immunodeficiency virus (HIV) acquisition. The overall 12-month cumulative probability of pregnancy of injectable contraceptive users was 0.6% (95% confidence interval [CI] 0.3-1.0), with similar risks in Uganda (0.3%, 95% CI 0-0.7), Thailand (0.6%, 95% CI 0-1.2), and Zimbabwe (1.0%, 95% CI 0.3-1.7). The 12-month cumulative probability of pregnancy for OCP users was 9.5% (95% CI 8.1-11.0%), with similar risks of pregnancy in Uganda and Zimbabwe (14.6%, 95% CI 11.7-17.4; and 10.2%, 95% CI 8.0-12.5, respectively) but substantially lower risk in Thailand (0.5%, 95% CI 0-1.2). The overall 12-month cumulative probability of pregnancy for women intending to use a given method at baseline was 2.0% (95% CI 1.4-2.6%) for injectable contraceptives, 15.7% (95% CI 14.1-17.3%) for OCPs, and 25.8% (95% CI 23.2-28.4) for condoms. Women in Thailand experienced lower pregnancy risk with condoms (18.4%, 95% CI 11.1-25.7) than in Uganda (29.5%, 95% CI 25.7-33.4), and Zimbabwe (23.3%, 95% CI 19.4-27.2). The overall risk of pregnancy for injectable contraceptive users was substantially lower than for oral contraceptive pill users. However, Thai participants had similarly low cumulative pregnancy probabilities for both methods. Women receiving contraceptive counseling should be informed that their experience with a given method may differ from the average or typical-use pregnancy rates often discussed during contraceptive counseling. Tailored counseling is necessary for women to make informed choices. II.Keywords
This publication has 17 references indexed in Scilit:
- Hormonal contraception and the risk of HIV acquisitionAIDS, 2007
- Prostate-Specific Antigen to Ascertain Reliability of Self-Reported Coital Exposure to SemenSexually Transmitted Diseases, 2006
- Contraceptive failure in the United StatesContraception, 2004
- Understanding risk: a randomized controlled trial of communicating contraceptive effectivenessObstetrics & Gynecology, 2003
- Steroid hormone contraception and bone mineral density: a cross-sectional study in an international populationObstetrics & Gynecology, 2000
- Preferences for Contraceptive Attributes: Voices of Women in Ciudad Juarez, MexicoInternational Family Planning Perspectives, 1997
- Clinical performance of the TCu 380A and TCu 220C IUDs in four developing country family planning clinicsContraception, 1994
- Multinational comparative clinical trial of long-acting injectable contraceptives: Norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final reportContraception, 1983
- A randomized, double-blind study of six combined oral contraceptivesContraception, 1982
- Plasma levels and pharmacokinetics of ethynyl estrogens in various populationsContraception, 1980